<p>Humana Inc.（纽约证券交易所代码：HUM - 获取免费报告）周一股价下跌 2.9%。该公司股价最低曾达到 288.00 美元，最后交易价为 286.51 美元。在交易中，共成交 153,686 股，较平均交易量 1,746,191 股下降了 91%。该股票此前收盘价为 295.04 美元。</p>
<h2>华尔街分析师观点</h2>
<ul>
<li>MarketBeat 周报 – 02/17 - 02/21</li>
</ul>
<p>HUM 已经成为多份研究报告的主题。Cantor Fitzgerald 在 2 月 12 日的研究报告中重申了对 Humana 的 “中性” 评级，并给出了 290.00 美元的目标价。Truist Financial 在周五将 Humana 的目标价从 290.00 美元上调至 325.00 美元，并给予该股票 “持有” 评级。加拿大皇家银行在 2 月 12 日的研究报告中重申了对 Humana 的 “跑赢大盘” 评级，并设定了 283.00 美元的目标价。StockNews.com 在 4 月 7 日的研究报告中将 Humana 的评级从 “持有” 上调至 “买入”。最后，摩根士丹利在 2 月 12 日的报告中将 Humana 的目标价从 301.00 美元下调至 285.00 美元，并对该公司设定了 “等权重” 评级。十七位分析师对该股票给予了持有评级，七位分析师给予了买入评级。根据 MarketBeat.com 的数据，该公司的平均评级为 “持有”，平均目标价为 288.60 美元。</p>
<p><strong>查看我们关于 Humana 的最新研究报告</strong></p>
<h2>Humana 价格表现</h2>
<ul>
<li>Humana 尽管在医疗保险优势上遭遇损失，但仍实现增长——原因何在？</li>
</ul>
<p>该公司的市值为 342.4 亿美元，市盈率为 28.52，市盈增长比率为 2.05，贝塔值为 0.62。该公司的债务与股本比率为 0.68，速动比率为 1.76，流动比率为 1.76。该股票的 50 日移动平均线为 265.55 美元，200 日移动平均线为 270.35 美元。</p>
<p>Humana（纽约证券交易所代码：HUM - 获取免费报告）最近在 2 月 11 日发布了季度财报。该保险提供商报告季度每股收益为（2.16 美元），超出市场共识预期的（2.26 美元）0.10 美元。Humana 的净利润率为 1.02%，股本回报率为 11.70%。股票分析师预测 Humana Inc.在当前年度的每股收益将达到 16.47 美元。</p>
<h2>Humana 宣布分红</h2>
<ul>
<li>Cigna 每股收益未达预期：这对健康保险行业意味着什么</li>
</ul>
<p>该公司最近还披露了季度分红，将于 4 月 25 日（星期五）支付。3 月 28 日（星期五）的股东将获得 0.885 美元的分红。这相当于每年 3.54 美元的分红，收益率为 1.25%。该分红的除息日为 3 月 28 日（星期五）。Humana 的派息比率目前为 35.58%。</p>
<h2>机构资金流入和流出</h2>
<p>一些对冲基金和其他机构投资者最近对 HUM 的持仓进行了调整。Dodge &amp; Cox 在第四季度将其在 Humana 的持股增加了 106.7%。Dodge &amp; Cox 目前拥有 10,198,040 股该保险提供商的股票，价值 2,587,345,000 美元，此前在上个季度又购买了 5,264,045 股。Vanguard Group Inc.在第四季度将其在 Humana 的持股增加了 15.8%。Vanguard Group Inc.目前拥有 12,829,210 股该保险提供商的股票，价值 3,254,899,000 美元，此前在上个季度又购买了 1,751,857 股。挪威银行在第四季度获得了 Humana 的新股份，价值约为 416,202,000 美元。Pzena Investment Management LLC 在第四季度将其在 Humana 的持股增加了 44.0%。Pzena Investment Management LLC 目前拥有 3,609,382 股该保险提供商的股票，价值 915,736,000 美元，此前在上个季度又购买了 1,103,132 股。最后，Boston Partners 在第四季度将其在 Humana 的持股增加了 435.8%。Boston Partners 目前拥有 1,098,702 股该保险提供商的股票，价值 279,236,000 美元，此前在上个季度又购买了 893,637 股。对冲基金和其他机构投资者持有该公司 92.38% 的股份。</p>
<h2>Humana 公司简介</h2>
<p>（获取免费报告）</p>
<p>Humana Inc 及其子公司在美国提供医疗和专业保险产品。它通过保险和 CenterWell 两个部门运营。该公司为个人提供医疗和补充福利计划。它与医疗保险和医疗补助服务中心签订合同，管理有限收入新合格过渡处方药计划；并与各州签订合同，提供医疗补助、双重合格和长期支持服务福利。</p>
<h2>精选文章</h2>
<ul>
<li>我们更看好的五只股票而非 Humana</li>
<li>如何选择评级最高的股票</li>
<li>第一季度内部人士购买的三只大型股票：买入、卖出或持有</li>
<li>专家股票交易心理学技巧</li>
<li>三只在 2025 年市场低迷中逆势而上的热门新 IPO</li>
<li>投资者如何从盘后交易中获益</li>
<li>三只以折扣价交易的高收益分红股票</li>
</ul>
<p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。如对该故事有任何问题或意见，请发送邮件至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在 Humana 吗？</h2>
<p>在你考虑 Humana 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街评级最高和表现最佳的研究分析师及其推荐的股票。MarketBeat 已识别出五只股票，顶级分析师正在悄悄地向客户推荐，现在就买入，以便在更广泛的市场注意到之前……而 Humana 并不在名单上。</p>
<p>虽然 Humana 目前在分析师中获得了持有评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

休曼纳

<p>休曼纳（Humana Inc.，NYSE:HUM）股价下跌 2.9%，至 286.51 美元，交易量较平均水平下降 91%。分析师们的看法不一，Cantor Fitzgerald 维持 “中性” 评级，目标价为 290 美元，而 Truist Financial 则将目标价上调至 325 美元。该公司报告的季度每股收益为（-2.16 美元），超出预期，并宣布季度股息为 0.885 美元。机构投资者持有 92.38% 的股份，Dodge & Cox 和 Vanguard Group 的持股显著增加</p>

<p>Humana Inc. (NYSE:HUM - Get Free Report) shares traded down 2.9% on Monday . The company traded as low as $288.00 and last traded at $286.51. 153,686 shares traded hands during trading, a decline of 91% from the average session volume of 1,746,191 shares. The stock had previously closed at $295.04.</p>
<div class="lb-trans"><p>Humana Inc.（纽约证券交易所代码：HUM - 获取免费报告）周一股价下跌 2.9%。该公司股价最低曾达到 288.00 美元，最后交易价为 286.51 美元。在交易中，共成交 153,686 股，较平均交易量 1,746,191 股下降了 91%。该股票此前收盘价为 295.04 美元。</p>
</div><h2>Wall Street Analyst Weigh In</h2>
<div class="lb-trans"><h2>华尔街分析师观点</h2>
</div><ul>
<li>MarketBeat Week in Review – 02/17 - 02/21</li>
</ul>
<div class="lb-trans"><ul>
<li>MarketBeat 周报 – 02/17 - 02/21</li>
</ul>
</div><p>HUM has been the subject of several research reports. Cantor Fitzgerald reissued a &#34;neutral&#34; rating and issued a $290.00 price objective on shares of Humana in a research report on Wednesday, February 12th. Truist Financial increased their price objective on Humana from $290.00 to $325.00 and gave the stock a &#34;hold&#34; rating in a research note on Friday. Royal Bank of Canada reaffirmed an &#34;outperform&#34; rating and set a $283.00 target price on shares of Humana in a research report on Wednesday, February 12th. StockNews.com raised Humana from a &#34;hold&#34; rating to a &#34;buy&#34; rating in a research report on Monday, April 7th. Finally, Morgan Stanley decreased their price objective on Humana from $301.00 to $285.00 and set an &#34;equal weight&#34; rating for the company in a report on Wednesday, February 12th. Seventeen analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. According to data from MarketBeat.com, the company has an average rating of &#34;Hold&#34; and an average price target of $288.60.</p>
<div class="lb-trans"><p>HUM 已经成为多份研究报告的主题。Cantor Fitzgerald 在 2 月 12 日的研究报告中重申了对 Humana 的 “中性” 评级，并给出了 290.00 美元的目标价。Truist Financial 在周五将 Humana 的目标价从 290.00 美元上调至 325.00 美元，并给予该股票 “持有” 评级。加拿大皇家银行在 2 月 12 日的研究报告中重申了对 Humana 的 “跑赢大盘” 评级，并设定了 283.00 美元的目标价。StockNews.com 在 4 月 7 日的研究报告中将 Humana 的评级从 “持有” 上调至 “买入”。最后，摩根士丹利在 2 月 12 日的报告中将 Humana 的目标价从 301.00 美元下调至 285.00 美元，并对该公司设定了 “等权重” 评级。十七位分析师对该股票给予了持有评级，七位分析师给予了买入评级。根据 MarketBeat.com 的数据，该公司的平均评级为 “持有”，平均目标价为 288.60 美元。</p>
</div><p><strong>Check Out Our Latest Research Report on Humana</strong></p>
<div class="lb-trans"><p><strong>查看我们关于 Humana 的最新研究报告</strong></p>
</div><h2>Humana Price Performance</h2>
<div class="lb-trans"><h2>Humana 价格表现</h2>
</div><ul>
<li>Humana Gains Despite Medicare Advantage Losses—What’s the Catch?</li>
</ul>
<div class="lb-trans"><ul>
<li>Humana 尽管在医疗保险优势上遭遇损失，但仍实现增长——原因何在？</li>
</ul>
</div><p>The company has a market cap of $34.24 billion, a PE ratio of 28.52, a price-to-earnings-growth ratio of 2.05 and a beta of 0.62. The company has a debt-to-equity ratio of 0.68, a quick ratio of 1.76 and a current ratio of 1.76. The stock has a 50 day moving average of $265.55 and a 200-day moving average of $270.35.</p>
<div class="lb-trans"><p>该公司的市值为 342.4 亿美元，市盈率为 28.52，市盈增长比率为 2.05，贝塔值为 0.62。该公司的债务与股本比率为 0.68，速动比率为 1.76，流动比率为 1.76。该股票的 50 日移动平均线为 265.55 美元，200 日移动平均线为 270.35 美元。</p>
</div><p>Humana (NYSE:HUM - Get Free Report) last posted its quarterly earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) EPS for the quarter, beating the consensus estimate of ($2.26) by $0.10. Humana had a net margin of 1.02% and a return on equity of 11.70%. Equities analysts predict that Humana Inc. will post 16.47 earnings per share for the current year.</p>
<div class="lb-trans"><p>Humana（纽约证券交易所代码：HUM - 获取免费报告）最近在 2 月 11 日发布了季度财报。该保险提供商报告季度每股收益为（2.16 美元），超出市场共识预期的（2.26 美元）0.10 美元。Humana 的净利润率为 1.02%，股本回报率为 11.70%。股票分析师预测 Humana Inc.在当前年度的每股收益将达到 16.47 美元。</p>
</div><h2>Humana Announces Dividend</h2>
<div class="lb-trans"><h2>Humana 宣布分红</h2>
</div><ul>
<li>Cigna Misses EPS: What It Means for the Health Insurance Industry</li>
</ul>
<div class="lb-trans"><ul>
<li>Cigna 每股收益未达预期：这对健康保险行业意味着什么</li>
</ul>
</div><p>The firm also recently disclosed a quarterly dividend, which will be paid on Friday, April 25th. Shareholders of record on Friday, March 28th will be issued a $0.885 dividend. This represents a $3.54 annualized dividend and a yield of 1.25%. The ex-dividend date of this dividend is Friday, March 28th. Humana's payout ratio is currently 35.58%.</p>
<div class="lb-trans"><p>该公司最近还披露了季度分红，将于 4 月 25 日（星期五）支付。3 月 28 日（星期五）的股东将获得 0.885 美元的分红。这相当于每年 3.54 美元的分红，收益率为 1.25%。该分红的除息日为 3 月 28 日（星期五）。Humana 的派息比率目前为 35.58%。</p>
</div><h2>Institutional Inflows and Outflows</h2>
<div class="lb-trans"><h2>机构资金流入和流出</h2>
</div><p>A number of hedge funds and other institutional investors have recently made changes to their positions in HUM. Dodge &amp; Cox lifted its holdings in Humana by 106.7% during the fourth quarter. Dodge &amp; Cox now owns 10,198,040 shares of the insurance provider's stock valued at $2,587,345,000 after purchasing an additional 5,264,045 shares in the last quarter. Vanguard Group Inc. lifted its stake in Humana by 15.8% in the 4th quarter. Vanguard Group Inc. now owns 12,829,210 shares of the insurance provider's stock valued at $3,254,899,000 after buying an additional 1,751,857 shares in the last quarter. Norges Bank acquired a new stake in Humana in the 4th quarter worth about $416,202,000. Pzena Investment Management LLC increased its stake in Humana by 44.0% during the 4th quarter. Pzena Investment Management LLC now owns 3,609,382 shares of the insurance provider's stock worth $915,736,000 after buying an additional 1,103,132 shares in the last quarter. Finally, Boston Partners raised its holdings in shares of Humana by 435.8% during the fourth quarter. Boston Partners now owns 1,098,702 shares of the insurance provider's stock valued at $279,236,000 after acquiring an additional 893,637 shares during the last quarter. Hedge funds and other institutional investors own 92.38% of the company's stock.</p>
<div class="lb-trans"><p>一些对冲基金和其他机构投资者最近对 HUM 的持仓进行了调整。Dodge &amp; Cox 在第四季度将其在 Humana 的持股增加了 106.7%。Dodge &amp; Cox 目前拥有 10,198,040 股该保险提供商的股票，价值 2,587,345,000 美元，此前在上个季度又购买了 5,264,045 股。Vanguard Group Inc.在第四季度将其在 Humana 的持股增加了 15.8%。Vanguard Group Inc.目前拥有 12,829,210 股该保险提供商的股票，价值 3,254,899,000 美元，此前在上个季度又购买了 1,751,857 股。挪威银行在第四季度获得了 Humana 的新股份，价值约为 416,202,000 美元。Pzena Investment Management LLC 在第四季度将其在 Humana 的持股增加了 44.0%。Pzena Investment Management LLC 目前拥有 3,609,382 股该保险提供商的股票，价值 915,736,000 美元，此前在上个季度又购买了 1,103,132 股。最后，Boston Partners 在第四季度将其在 Humana 的持股增加了 435.8%。Boston Partners 目前拥有 1,098,702 股该保险提供商的股票，价值 279,236,000 美元，此前在上个季度又购买了 893,637 股。对冲基金和其他机构投资者持有该公司 92.38% 的股份。</p>
</div><h2>Humana Company Profile</h2>
<div class="lb-trans"><h2>Humana 公司简介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.</p>
<div class="lb-trans"><p>Humana Inc 及其子公司在美国提供医疗和专业保险产品。它通过保险和 CenterWell 两个部门运营。该公司为个人提供医疗和补充福利计划。它与医疗保险和医疗补助服务中心签订合同，管理有限收入新合格过渡处方药计划；并与各州签订合同，提供医疗补助、双重合格和长期支持服务福利。</p>
</div><h2>Featured Articles</h2>
<div class="lb-trans"><h2>精选文章</h2>
</div><ul>
<li>Five stocks we like better than Humana</li>
<li>How to Choose Top Rated Stocks</li>
<li>Top 3 Large Cap Stocks Insiders Bought in Q1: Buy, Sell, or Hold</li>
<li>Expert Stock Trading Psychology Tips</li>
<li>3 Hot New IPOs Defying the 2025 Market Slump</li>
<li>How Can Investors Benefit From After-Hours Trading</li>
<li>3 High-Yield Dividend Stocks Trading at a Discount</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票而非 Humana</li>
<li>如何选择评级最高的股票</li>
<li>第一季度内部人士购买的三只大型股票：买入、卖出或持有</li>
<li>专家股票交易心理学技巧</li>
<li>三只在 2025 年市场低迷中逆势而上的热门新 IPO</li>
<li>投资者如何从盘后交易中获益</li>
<li>三只以折扣价交易的高收益分红股票</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。如对该故事有任何问题或意见，请发送邮件至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Humana Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在 Humana 吗？</h2>
</div><p>Before you consider Humana, you'll want to hear this.</p>
<div class="lb-trans"><p>在你考虑 Humana 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Humana wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街评级最高和表现最佳的研究分析师及其推荐的股票。MarketBeat 已识别出五只股票，顶级分析师正在悄悄地向客户推荐，现在就买入，以便在更广泛的市场注意到之前……而 Humana 并不在名单上。</p>
</div><p>While Humana currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Humana 目前在分析师中获得了持有评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

休曼纳（NYSE:HUM）股价下跌 2.9% - 现在是卖出的时候吗？